Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Functional Intact Fibrinogen (FiF) test superior to Clauss for cardiovascular risk :

This article was originally published in Clinica

Executive Summary

American Biogenetic Sciences' Functional Intact Fibrinogen test is an accurate means of assessing risk in cardiovascular disease patients, say Framingham Heart study researchers. The test, which measures elevated fibrinogen levels in the blood, showed a closer correlation with cardiovascular disease than the commonly-used Clauss method, says ABS. The company hopes to file for 510(k) clearance later this year and expects to see fibrinogen testing incorporated into routine practice in the future.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT088037

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel